Volume 5, Issue 2 (Journal of Clinical and Basic Research (JCBR) 2021)
jcbr 2021, 5(2): 17-25 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Parhiz J, Rahafard S, Sharifi S, Kompani F. Comparison of Co-trimoxazole and Cephalexin Efficacy in Preventing Urinary
Tract Infection among Children. jcbr 2021; 5 (2) :17-25
URL: http://jcbr.goums.ac.ir/article-1-309-en.html
URL: http://jcbr.goums.ac.ir/article-1-309-en.html
1- Neonatal and Children's Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Abstract: (4964 Views)
Background and objectives: Diagnosis and treatment of urinary tract infection (UTI) in children before kidney damage is necessary. The purpose of this study was to compare efficacy of co-trimoxazole and cephalexin in the prevention of recurrent UTI in children.
Methods: The study was performed on 100 children aged three months to 14 years who were referred to the Taleghani Pediatric Hospital in Gorgan (Iran) during 2016. The subjects had a history of UTI and required antibiotic prophylaxis to prevent UTI. They were divided into two groups of co-trimoxazole and cephalexin. Data were analyzed using SPSS (version 18) and at significance level of 0.05.
Results: Recurrent UTI was observed in eight children (16.0%) taking cephalexin and in six children (12.0%) receiving co-trimoxazole (p=0.56). Urine culture examination revealed Escherichia coli as the causative agent of UTI in six cases (75 %) receiving cephalexin and in five cases (83.3%) receiving co-trimoxazole (p=0.70). It should be noted that unilateral moderate hydronephrosis was the most frequent anomaly (n=26) in the study groups.
Conclusion: According to the results of the present study, both cephalexin and co-trimoxazole have similar efficacy in the prevention of UTI among children.
Methods: The study was performed on 100 children aged three months to 14 years who were referred to the Taleghani Pediatric Hospital in Gorgan (Iran) during 2016. The subjects had a history of UTI and required antibiotic prophylaxis to prevent UTI. They were divided into two groups of co-trimoxazole and cephalexin. Data were analyzed using SPSS (version 18) and at significance level of 0.05.
Results: Recurrent UTI was observed in eight children (16.0%) taking cephalexin and in six children (12.0%) receiving co-trimoxazole (p=0.56). Urine culture examination revealed Escherichia coli as the causative agent of UTI in six cases (75 %) receiving cephalexin and in five cases (83.3%) receiving co-trimoxazole (p=0.70). It should be noted that unilateral moderate hydronephrosis was the most frequent anomaly (n=26) in the study groups.
Conclusion: According to the results of the present study, both cephalexin and co-trimoxazole have similar efficacy in the prevention of UTI among children.
Article Type: Research |
Subject:
Basic medical sciences
References
1. Newman TB. The new American Academy of Pediatrics urinary tract infection guideline. Pediatrics. 2011;128(3):572-5. [View at Publisher] [DOI] [PubMed] [Google Scholar]
2. Taneja N, Chatterjee SS, Singh M, Singh S, Sharma M. Pediatric urinary tract infections in a tertiary care center from north India. Indian journal of medical research. 2010;131(1):101-6. [PubMed] [Google Scholar]
3. Swerkersson S. Urinary tract infection in small children: aspects of bacteriology, vesicoureteral reflux and renal damage. 2016. [View at Publisher] [Google Scholar]
4. Yousefi P, Cyrus A, Moghaddasi Z, Dorreh F, Aravand A. The frequency of recurrence of urinary tract infection (UTI) in 1-month to 12-year-old children without congenital abnormalities referred to Arak Amir Kabir Hospital. J Adv Med Biomed Res. 2011;19(76):66-76. [View at Publisher] [Google Scholar]
5. Nickavar A, Sotoudeh K. Treatment and prophylaxis in pediatric urinary tract infection. International journal of preventive medicine. 2011;2(1):4. [View at Publisher] [PubMed] [Google Scholar]
6. Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics. 2015;136(1):e13-e21. [View at Publisher] [DOI] [PubMed] [Google Scholar]
7. Kliegman RM, Behrman RE, Jenson HB, Stanton BM. Nelson textbook of pediatrics e-book: Elsevier Health Sciences; 2007. [View at Publisher] [Google Scholar]
8. Chaudhry R, Balsara ZR, Madden-Fuentes RJ, Wiener JS, Routh JC, Seed P, et al. Risk factors associated with recurrent urinary tract infection in neurogenic bladders managed by clean intermittent catheterization. Urology. 2017;102:213-8. [View at Publisher] [DOI] [PubMed] [Google Scholar]
9. Karpman E, Kurzrock EA. Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. The Journal of urology. 2004;172(2):448-53. [View at Publisher] [DOI] [PubMed] [Google Scholar]
10. Simalti A. Pseudotumour cerebri: A side-effect of nalidixic acid. Acta Medica International. 2014;1(1):325-37. [View at Publisher] [DOI] [Google Scholar]
11. Falagas ME, Polemis M, Alexiou VG, Marini-Mastrogiannaki A, Kremastinou J, Vatopoulos AC. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. Medical Science Monitor. 2008;14(2):CR75-CR9. [View at Publisher] [PubMed] [Google Scholar]
12. Cheng C-H, Tsai M-H, Huang Y-C, Su L-H, Tsau Y-K, Lin C-J, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics. 2008;122(6):1212-7. [View at Publisher] [DOI] [PubMed] [Google Scholar]
13. Valavi E, Nikfar R, Ahmadzadeh A, Kompani F, Najafi R, Hoseini R. The last three years antibiotic susceptibility patterns of uropathogens in southwest of Iran. 2013. [View at Publisher] [DOI] [Google Scholar]
14. Ghane Sharbaf F, Esmaeili M, Esmaeili M. Comparison of Nalidixic acid and Trimethoprim â sulfamethoxazole in prophylaxis of recurrent urinary tract infection in children. medical journal of mashhad university of medical sciences. 2015;58(4):175-84. [View at Publisher] [Google Scholar]
15. Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. bmj. 2016;352. [View at Publisher] [DOI] [PubMed] [Google Scholar]
16. Amirhassani S, Mosavi Bahar SHA. Comparative Study of Effectiveness of Long Term Low Dose of Naldixic Acid and Cotrimoxazolee in Patients with Recurrent Urinary Tract Infections. Avicenna Journal of Clinical Medicine. 2012;19(1):11-5. [View at Publisher] [Google Scholar]
17. Mori R, Fitzgerald A, Williams C, Tullus K, Verrier‐Jones K, Lakhanpaul M. Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systematic review. Acta Paediatrica. 2009;98(11):1781-6. [View at Publisher] [DOI] [PubMed] [Google Scholar]
18. Karimpour HA, Mohamadi S. The study of frequency and antibiotic resistance pattern of urinary tract infection pathogens in children of Kermanshah in 2015. Razi Journal of Medical Sciences. 2017;24(155):20-7. [View at Publisher] [Google Scholar]
19. Dodge WF, West EF, Travis LB. Bacteriuria in school children: Observations on outcome following detection in 110 girls. American Journal of Diseases of Children. 1974;127(3):364-70. [View at Publisher] [DOI] [PubMed] [Google Scholar]
20. Sorkhi H, Zamani N, Bijani A. Evaluation of discontinuation of antibacterial prophylaxis in children with vesicoureteral reflux. Journal of Shahrekord University of Medical Sciences. 2012;14(3):72-80. [View at Publisher] [Google Scholar]
21. Gillenwater JY, Harrison RB, Kunin CM. Natural history of bacteriuria in schoolgirls: A long-term case-control study. New England Journal of Medicine. 1979;301(8):396-9. [View at Publisher] [DOI] [PubMed] [Google Scholar]
22. Paschke AA, Zaoutis T, Conway PH, Xie D, Keren R. Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children. Pediatrics. 2010;125(4):664-72. [View at Publisher] [DOI] [PubMed] [Google Scholar]
23. Zainal D, Baba A. The value of positive nitrites in screening asymptomatic bacteriuria amongst Malaysian school children. The Southeast Asian journal of tropical medicine and public health. 1996;27(1):184-8. [View at Publisher] [PubMed] [Google Scholar]
24. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerging infectious diseases. 2010;16(1):88. [View at Publisher] [DOI] [PubMed] [Google Scholar]
25. Sabzehei MK, Basiri B, Shokouhi M, Eghbalian F. Urinary tract infection profile among a hospitalized newborn: a single center study in Iran, 2006-2015. Medical Journal of Indonesia. 2018;27(2):94â 100-94â [View at Publisher] [DOI] [Google Scholar]
26. Bremberg SG, Edström S. Outcome assessment of routine medical practice in handling child urinary tract infections: estimation of renal scar incidence. Ambulatory child health. 2001;7(3‐4):149-55. [View at Publisher] [Google Scholar]
27. Neilson EG. Pathogenesis and therapy of interstitial nephritis. Kidney international. 1989;35(5):1257-70. [View at Publisher] [DOI] [PubMed] [Google Scholar]
28. Litaka K, Sakai T, Oyama K, Izawa T, Igarashi S. Screening for bacteriuria in Japanese school children. Pediatrics International. 1990;32(6):690-5. [View at Publisher] [DOI] [Google Scholar]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).